Candel Therapeutics (CADL) Shares Outstanding (Entity) (2020 - 2025)

Candel Therapeutics (CADL) Shares Outstanding (Entity) (2020 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 254.16 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 200.18 Mn
10 Candel Therapeutics 504.70 Mn 504.70 Mn - 55.02 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 55.02 Mn
Sep 30, 2025 55.02 Mn
Jun 30, 2025 55.01 Mn
Mar 31, 2025 49.37 Mn
Dec 31, 2024 31.68 Mn
Sep 30, 2024 32.25 Mn
Jun 30, 2024 31.19 Mn
Mar 31, 2024 29.47 Mn
Dec 31, 2023 29.21 Mn
Sep 30, 2023 29.04 Mn
Jun 30, 2023 29.04 Mn
Mar 31, 2023 29.04 Mn
Dec 31, 2022 29.04 Mn
Sep 30, 2022 29.01 Mn
Jun 30, 2022 29.01 Mn
Mar 31, 2022 28.69 Mn
Dec 31, 2021 18.87 Mn
Sep 30, 2021 23.33 Mn
Jun 30, 2021 11.73 Mn
Mar 31, 2021 11.65 Mn